For the Inventor, By the Inventor

Enter inventor name

Boston, MA, United States of America

Gerald W Shipps

USPTO Granted Patents = 8 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 19 (Patent Applications = 17)

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Stoneham, MA (US) (2001 - 2007)
Boston, MA (US) (2020 - 2023)

Company Filing History:

Bantam Pharmaceutical, LLC

Schering Corporation

Neogenesis, Inc.

Neogenesis Drug Discovery, Inc.

Years Active: 2001-2024

Loading Chart...

Loading Chart...

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12150934 - Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases (2024-11-26),

2. 11602526 - Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto (2023-03-14),

3. 11325903 - Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases (2022-05-10),

4. 10537558 - Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto (2020-01-21),

5. 7269519 - Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation (2007-09-11),

6. 7196111 - Pyrazolo[1,5a]pyrimidine compounds as antiviral agents (2007-03-27),

7. 6714875 - Method for producing and screening mass-coded combinatorial libraries for drug discovery and target validation (2004-03-30),

8. 6207861 - Method for producing and screening mass coded combinatorial libraries for drug discovery and target validation (2001-03-27),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…